Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 97,339Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Fintepla

PharmaCompass

01

Brand Name : Fintepla

Fenfluramine

arrow
APS Symposium
Not Confirmed

Brand Name : Fintepla

arrow
APS Symposium
Not Confirmed

Fenfluramine

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 124

2021 Revenue in Millions : 0

Growth (%) : New Launch in 2022

blank

02

Brand Name : Fintepla

Fenfluramine

arrow
APS Symposium
Not Confirmed

Brand Name : Fintepla

arrow
APS Symposium
Not Confirmed

Fenfluramine

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 244

2022 Revenue in Millions : 125

Growth (%) : -48

blank

03

Brand Name : Fintepla

Fenfluramine

arrow
APS Symposium
Not Confirmed

Brand Name : Fintepla

arrow
APS Symposium
Not Confirmed

Fenfluramine

Main Therapeutic Indication : Neurology

Currency : USD

2024 Revenue in Millions : 356

2023 Revenue in Millions : 244

Growth (%) : 46

blank